"In the United States, IQVIA reports annual sales for the 12 months ending December 2024 generated by the branded product and its generic competitors (with which Acrux’s product will compete) exceeding USD$43 million and 171,000 packs."
“We are very excited to launch this differentiated product which has been developed in house by the Acrux R&D team"
... we are so excited we forgot to include how much of that market we expect to gain over 1,2 and 3 years.... probably equates to $1,500 net revenue to ACR for every $1.5m in sales.
Add to My Watchlist
What is My Watchlist?
